t76362_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2013
Greenway Medical Technologies, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 001-35413
| |
|
|
|
Delaware
|
|
58-2412516
|
|
(State or other jurisdiction
of incorporation)
|
|
(IRS Employer
Identification No.)
|
100 Greenway Boulevard
Carrollton, GA 30117
(Address of principal executive offices, including zip code)
(770) 836-3100
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 2.02.
|
Results of Operations and Financial Condition
|
The following information is being furnished pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On April 29, 2013, Greenway Medical Technologies, Inc. issued a press release announcing certain preliminary financial information for the quarter ended March 31, 2013 as well as updated guidance for its 2013 fiscal year, a copy of which is furnished herewith as Exhibit 99.1.
|
Item 7.01
|
Regulation FD Disclosure.
|
The following information is being furnished pursuant to Item 7.01 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
The information contained in Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference to this Item 7.01.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
(d) Exhibits. |
| |
|
| |
The following exhibit is filed herewith.
|
|
Exhibit
No.
|
Description
|
|
99.1
|
Press Release dated April 29, 2013
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Greenway Medical Technologies, Inc. |
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/ William G. Esslinger, Jr. |
|
| |
|
William G. Esslinger, Jr. |
|
| |
|
Vice President, General Counsel and Secretary
|
|